Journal
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
Volume 1794, Issue 5, Pages 852-859Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.bbapap.2008.12.012
Keywords
Multidrug resistance; Transcription; ABC transporter; Candida albicans; Candida glabrata; Saccharomyces cerevisiae; Sphingolipid; Phospholipid asymmetry
Categories
Funding
- NIH [GM49825, GM75120]
- NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075120, R01GM049825] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Pathogenic fungi present a special problem in the clinic as the range of drugs that can be used to treat these types of infections is limited. This situation is further complicated by the presence of robust inducible gene networks encoding different proteins that confer tolerance to many available antifungal drugs. The transcriptional control of these multidrug resistance systems in several key fungi will be discussed. Experiments in the non-pathogenic Saccharomyces cerevisiae have provided much of our current understanding of the molecular framework on which fungal multidrug resistance is built. More recent studies on the important pathogenic Candida species. Candida albicans and Candida glabrata, have provided new insights into the organization of the multidrug resistance systems in these organisms. We will compare the circuitry of multidrug resistance networks in these three organisms and suggest that, in addition to the well-accepted drug efflux activities, the regulation of membrane composition by multidrug resistance proteins provides an important contribution to the resistant phenotypes observed. (C) 2008 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available